D. Clarke-Pearson - Concepedia

Author

D. Clarke-Pearson

Also Known As

D Clarke-Pearson, D L Clarke-Pearson, D. Clarke-Pearson, D. L. Clarke-Pearson, D.L. Clarke-Pearson, D.L. Clarke‐Pearson, Daniel Clarke-Pearson, Daniel L. Clarke–Pearson, Kumar, P.

Publications

674

Citations

H-Index

Concepts

All Affiliations

Duke Medical Center Duke University Gynecologic Oncology Group Duke University Hospital

About

D. Clarke-Pearson is an author at Duke Medical Center specializing in medicine, gynecology oncology, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	433
2	Obstetrics	8	8	344
3	Pathology	3	3	122
4	Public Health	2	2	109
5	Emergency Medicine	1	1	89

D. Clarke-Pearson

Publications

539

Citations

H-Index

Page 1

	Year	Citations
A randomized phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: A Gynecologic Oncology Group study Jay W. Carlson, James Kauderer, Joan L. Walker, Gynecologic Oncology Gynecologic SurgerySurgical OncologyGynecological SurgeryGynecologySurgery	2008	108
Venous thromboembolism prophylaxis: patients at high risk to fail intermittent pneumatic compression D. Clarke-Pearson Obstetrics and Gynecology Deep Venous ThrombosisLogistic AnalysisThrombosisVenous ThrombosisClinical Epidemiology	2003	89
The role of partial sigmoid colectomy for debulking epithelial ovarian carcinoma John T. Soper, Grace M. Couchman, Andrew Berchuck, Gynecologic Oncology Partial Sigmoid ColectomySurgical OncologyTumoral PathologyGynecological SurgeryMedicine	1991	62
Alternating weekly chemotherapy with etoposide‐methotrexatedactinomycin/cyclophosphamide‐vincristine for high‐risk gestational trophoblastic disease J.T. Soper, Anna Evans, D. Clarke-Pearson, International Journal of Gynecology & Obstetrics	1994	54
High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer Elizabeth J. Shpall, D. Clarke-Pearson, John T. Soper, Gynecologic Oncology Agent ChemotherapyMedicineMetronomic TherapyGynecologyMetronomic Chemotherapy	1990	53
Metastatic gestational trophoblastic disease: prognostic factors in previously untreated patients. John T. Soper, D. Clarke-Pearson, Charles B. Hammond PubMed Prognostic FactorsDisease DurationTumoral PathologyGastrointestinal OncologyMedicine	1988	49
Radical hysterectomy in obese women. Andrew P. Soisson, John T. Soper, Andrew Berchuck, PubMed	1992	42
Phase III study of intraperitoneal cisplatin-intravenous cyclophosphamide versus intravenous cisplatin-intravenous cyclophosphamide in patients with optimal disease stage III ovarian cancer: a SWOG-GOG-ECOG Intergroup study David S. Alberts, P. Y. Liu, Edward V. Hannigan, International Journal of Gynecological Cancer MedicineMetronomic TherapyGynecologyPhase Iii StudyIntravenous Cisplatin-intravenous Cyclophosphamide	1996	30
Computed tomography in evaluation of patients with ovarian carcinoma in complete clinical remission. Correlation with surgical-pathologic findings D. Clarke-Pearson JAMA Surgical OncologyOncologic ImagingPelvic Reconstructive SurgeryGynecologySurgery	1986	20
A phase II study to determine the efficacy and tolerability of intravenous ZD9331 in heavily pretreated patients with ovarian cancer Janet S. Rader, D. Clarke-Pearson, Malcolm Moore, Gynecologic Oncology MedicineCancer ManagementGynecologyPhase Ii StudyIntravenous Zd9331	2003	11

Page 1